Cargando…
Congenital hyperinsulinism in two siblings with ABCC8 mutation: same genotype, different phenotypes
Congenital hyperinsulinism (CHI) is a heterogenous disease caused by insulin secretion regulatory defects, being ABCC8/KCNJ11 the most commonly affected genes. Therapeutic options include diazoxide, somatostatin analogues and surgery, which is curative in focal CHI. We report the case of two sibling...
Autores principales: | Sousa-Santos, Francisco, Simões, Helder, Castro-Feijóo, Lidia, Rodríguez, Paloma Cabanas, Fernández-Marmiesse, Ana, Fiaño, Rebeca Saborido, Rego, Teresa, Carracedo, Ángel, Conde, Jesús Barreiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118649/ https://www.ncbi.nlm.nih.gov/pubmed/30462810 http://dx.doi.org/10.20945/2359-3997000000077 |
Ejemplares similares
-
Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism
por: Chandran, Suresh, et al.
Publicado: (2013) -
Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015) -
Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8
por: Mouron-Hryciuk, Julie, et al.
Publicado: (2021) -
Genotyping of ABCC8, KCNJ11, and HADH in Iranian Infants with Congenital Hyperinsulinism
por: Hashemian, Somayyeh, et al.
Publicado: (2021) -
Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutation
por: Mooij, Christiaan F., et al.
Publicado: (2021)